101
Participants
Start Date
June 2, 2020
Primary Completion Date
March 11, 2026
Study Completion Date
March 11, 2026
efgartigimod
Intravenous infusion of efgartigimod
Investigator Site 0010045, Washington D.C.
Investigator Site 0010037, Ocala
Investigator Site 0010040, Columbus
Investigator Site 0010042, Iowa City
Investigator Site 0430002, Vienna
Investigator Site 0430003, Vienna
Investigator Site 0320012, Brasschaat
Investigator Site 0320011, Bruges
Investigator Site 0320014, Turnhout
Investigator Site 0320002, Yvoir
Investigator Site 3590001, Pleven
Investigator Site 3590002, Sofia
Investigator Site 4200001, Brno
Investigator Site 4200008, Olomouc
Investigator Site 4200006, Ostrava
Investigator Site 4200007, Prague
Investigator Site 0330009, Créteil
Investigator Site 0330018, Montpellier
Investigator Site 0330008, Pessac
Investigator Site 0330016, Périgueux
Investigator site 9950007, Tbilisi
Investigator site 9950008, Tbilisi
Investigator site 9950009, Tbilisi
Investigator site 9950011, Tbilisi
Investigator site 9950012, Tbilisi
Investigator Site 0490010, Düsseldorf
Investigator Site 0490008, Essen
Investigator Site 0360004, Budapest
Investigator Site 0360006, Debrecen
Investigator Site 0360015, Győr
Investigator Site 0360010, Nyíregyháza
Investigator Site 0360014, Szombathely
Investigator Site 0390014, Milan
Investigator Site 0390020, Monza
Investigator Site 0390015, Novara
Investigator Site 0390010, Ravenna
Investigator Site 0390011, Reggio Calabria
Investigator Site 0390018, Reggio Emilia
Investigator Site 0390019, Rimini
Investigator Site 0390009, Siena
Investigator Site 0390016, Trieste
Investigator Site 0810015, Hirakata
Investigator Site 0810010, Hiroshima
Investigator Site 0810017, Iruma
Investigator Site 0810022, Kashiwa
Investigator Site 0810018, Maebashi
Investigator Site 0810021, Niigata
Investigator Site 0810014, Sapporo
Investigator Site 0810016, Shibukawa
Investigator Site 0810023, Shimotsuke
Investigator Site 0310005, Rotterdam
Investigator Site 0310006, The Hague
Investigator Site 0480012, Gdansk
Investigator Site 0480013, Katowice
Investigator Site 0480011, Lodz
Investigator Site 0480014, Lublin
Investigator Site 0480026, Nowy Sącz
Investigator Site 0070006, Kaluga
Investigator Site 0070008, Moscow
Investigator Site 0070007, Petrozavodsk
Investigator Site 0070013, Rostov-on-Don
Investigator Site 0070015, Syktyvkar
Investigator Site 0070012, Tula
Investigator Site 0070010, Ufa
Investigator Site 0340006, Barcelona
Investigator Site 0340007, Barcelona
Investigator Site 0340009, Madrid
Investigator Site 0340014, Madrid
Investigator Site 0340012, Palma de Mallorca
Investigator Site 0340015, Pozuelo de Alarcón
Investigator Site 0340013, Seville
Investigator Site 0340004, Valencia
Investigator Site 0340011, Valencia
Investigator Site 0900003, Ankara
Investigator Site 0900006, Ankara
Investigator Site 0900015, Ankara
Investigator Site 0900016, Edirne
Investigator Site 0900013, Istanbul
Investigator Site 0900004, Izmir
Investigator Site 0900010, Mersin
Investigator Site 0900007, Sakarya
Investigator Site 0900009, Samsun
Investigator Site 0900017, Tekirdağ
Investigator Site 0900019, Trabzon
Investigator Site 3800006, Mykolaiv
Investigator Site 0440008, London
Investigator Site 0440012, Southampton
Lead Sponsor
argenx
INDUSTRY